<DOC>
	<DOCNO>NCT02869685</DOCNO>
	<brief_summary>The detection tissue PD-L1 immunohistochemistry NSCLC important role guide treatment immune detection point.Radiation therapy enhance effect immunotherapy , radiation dose time wait solve . At time , tissue detection time-consuming laborious , liquid biopsy reflect information tumor tissue , PD-L1 mRNA plasma exosomes ( pExo ) expect simple , rapid , non-invasive mean detection . The project plan explore consistency analysis PD-L1 expression level detect tissue pExo radiotherapy.We design five kind radiation-division bioequivalent dos , detect expression level PD-L1 pExo 24h , 48h stage radiotherapy.PD-L1 mRNA level pExo detect different time point , use variance analysis repeat measure design information.Probing best timing manner radiotherapy division make PD-L1 express , guide clinical practice radiotherapy combine immunotherapy .</brief_summary>
	<brief_title>Clinical Research Consistency Analysis PD-L1 Lung Cancer Tissue Plasma Exosome Before After Radiotherapy</brief_title>
	<detailed_description />
	<criteria>1 . Pathological histology and/or cytology confirm NSCLC ; 2 . Based AJCC Cancer Staging , IIIA , IIIB , IV lung cancer patient NSCLC ; 3 . PS 02 ; 4 . Expected survival &gt; 3 month ; 5 . Age 18~75 year old ; 6 . The function lung , liver , kidney , bone marrow normal ; 7 . The patient receive radiotherapy previous primary tumor metastasis ; 8 . At least accept 2âˆ’4 cycle chemotherapy , disease progression chemotherapy , start radiotherapy two week last cycle chemotherapy ; 9 . Wildtype EGFR ; 10 . Sensitive mutant EGFR , refuse targeted therapy ; 11 . In line indication radiotherapy accept ; 12 . Voluntarily enrolled participate , good compliance , cooperate experimental observation , sign inform consent . 1 . Vital organ ( e.g. , heart , liver , kidney ) serious dysfunction ; 2 . Patients malignancy ; 3 . Patients history autoimmune disease ; 4 . The patient pregnant lactating ( Women childbearing age need check pregnancy test ) ; 5 . In activity acute chronic infectious disease ; 6 . Patients clear history drug allergy allergic genus ; 7 . Patients participate clinical trial time ; 8 . Other case researcher believe patient participate present trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>